The health care community has redefined the requirements for clinical obesity, noting BMI shouldn’t be the sole barometer of ...

Exposure to TNF inhibitors was linked to a reduced risk for cardiovascular events among patients with AS; the impact of IL-17 inhibitors was less clear.